BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent - P&T Community

BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent  P&T Community

ANN ARBOR, Mich., May 29, 2019 /PRNewswire/ -- BlueWillow Biologics today announced the issuance of U.S. patent number 10,138,279 covering an ...